Anticoagulants and antiplatelets are safe to use during pars plana vitrectomy - Ophthalmology Times Europe

Links shared publicly online about this topic.

0
total visits

Anticoagulants and antiplatelets are safe to use during pars plana vitrectomy - Ophthalmology Times Europe

Continuing the use of anticoagulants and antiplatelets during diabetic pars plana vitrectomy does not pose a higher risk of intraoperative or postoperative vitreous haemorrhage.

View full resource at oteurope.com

Tags: Diabetes, Anti-Clotting Medication, Anticoagulant, Ophthalmology, News, Safety

Most Recently Shared on November 21, 2011 at 12:48 pm By:

Richard Hom OD MPA

via @OTEurope: News Update: Anticoagulants and antiplatelets are safe to use during pars plana vitrectomy http://t.co/BUJTqUoQ

5 months ago...

Retweet

Favorite

Also Shared By:

$Ophthalmology Times Europe magazine: latest news in cataract, refractive, retina, glaucoma and more$ Ophthalmology Times

OrganizedWisdom

Anticoagulants and antiplatelets are safe to use during pars plana vitrectomy - Ophthalmology Times Europe

Anticoagulants and antiplatelets are safe to use during pars plana vitrectomy - Ophthalmology Times Europe

Most Recently Shared on November 21, 2011 at 12:48 pm By:

Also Shared By:

Verify on Twitter to Claim Your Profile

Make an Appointment

Consulting Inquiry

Verify Information